Washington, D.C., April 15, 2015 The U.S. Senate overwhelmingly approved legislation last night for a two-year extension of the Special Diabetes Program (SDP)an initiative that accounts for roughly one-third of all Federally-funded type 1 diabetes (T1D) research in the United States. The decision comes on the heels of the strong bipartisan approval of the legislation on March 26 by the U.S. House of Representatives, and will extend SDP funding for the National Institutes of Health (NIH) at the current level of $150 million, per year, as part of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2). The President is expected to sign the legislation into law today.
